Codex DNA Announces Commercial Availability of Automated mRNA Synthesis Kit with Integrated Capping Technology for BioXp™ System

Codex DNA Announces Commercial Availability of Automated mRNA Synthesis Kit with Integrated Capping Technology for BioXp™ System

Codex DNA Announces Commercial Availability of Automated mRNA Synthesis Kit with Integrated Capping Technology for BioXp™ System
ExCellThera announces data to be presented at the American Society of Hematology 2021 annual meeting
Ceapro Inc. Announces R&D Funding to Support PGX Technology Project
TRACON Pharmaceuticals Reports Regulatory Approval of Envafolimab in China
Celsion Corporation Invited to Present Poster at Cytokine-Based Cancer Immunotherapies Summit
Greenrose Acquisition Corp. Announces Closing of Business Combination with Theraplant
BioCryst Begins Patient Enrollment in REDEEM-2 Pivotal Trial Evaluating BCX9930 as Oral Monotherapy for Patients with PNH
SCYNEXIS to Host Ibrexafungerp Hospital Pipeline Update Call and KOL Webcast for Investors on December 6
Artelo Biosciences Reports Fiscal 2021 Year-End Financial Results and Provides Business Update
RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord…